This prospective randomized, double-blind, placebo-controlled trial looked at the use of prednisone 40 mg daily for 10 days vs. placebo in 147 patients presenting to any of 10 emergency departments who were well enough to be discharged after treatment for exacerbation of their chronic obstructive pulmonary disease.
This prospective randomized, double-blind, placebo-controlled trial looked at the use of prednisone 40 mg daily for 10 days vs. placebo in 147 patients presenting to any of 10 emergency departments who were well enough to be discharged after treatment for exacerbation of their chronic obstructive pulmonary disease.
Burst Steroid Therapy for COPD Exacerbations
September 1, 2003